|
|
|
|
A more recent version of this article appeared on June 1, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 16, 2003
Revised on March 19, 2004
Accepted on March 22, 2004
1 Department of Biochemistry and Molecular Biology, Penn State University, University Park, PA 16802
2 Department of Biology, Clarion University, Clarion, PA 16214
3 Department of Biology, Amherst College, Amherst, MA 01002
* Corresponding author. E-mail address: ur3{at}psu.edu.
When cells undergo apoptosis, or programmed cell death, they expose phosphatidylserine (PS), on their surface. Macrophages that efficiently phagocytose apoptotic cells also express PS on their surface, although at a lower level. The PS exposed on both cells is required for phagocytosis, since uptake is inhibited by masking PS on either cell with annexin V, a PS-binding protein. The inhibition is not additive, suggesting that the exposed PS molecules on the two cells participate in a common process. We asked whether this dual requirement reflects bridging of the target cell and macrophage by bivalent, PS-binding annexins. Monoclonal antibodies (mAbs) against annexins I or II stained a variety of live phagocytes. Apoptotic Jurkat T lymphocytes and human peripheral T lymphocytes, but not apoptotic thymocytes, were stained by antiannexin I but not II. Phagocytosis of apoptotic targets was inhibited by mAbs to annexins I or II, or by pretreatment of macrophages with the same mAbs. Pretreatment of apoptotic thymocytes had no effect, while pretreating Jurkat cells with antiannexin I or removing annexin I with EGTA was inhibitory. Annexin bridging is vectorial, since annexin is bound to PS molecules on targets but not on macrophages, suggesting annexins serve as both ligand and receptor in promoting phagocytosis.
This article has been cited by other articles:
![]() |
Z. V. Popovic, R. Sandhoff, T. P. Sijmonsma, S. Kaden, R. Jennemann, E. Kiss, E. Tone, F. Autschbach, N. Platt, E. Malle, et al. Sulfated Glycosphingolipid as Mediator of Phagocytosis: SM4s Enhances Apoptotic Cell Clearance and Modulates Macrophage Activity J. Immunol., November 15, 2007; 179(10): 6770 - 6782. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. A. Swisher, U. Khatri, and G. M. Feldman Annexin A2 is a soluble mediator of macrophage activation J. Leukoc. Biol., November 1, 2007; 82(5): 1174 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhatnagar, K. Shinagawa, F. J. Castellino, and J. S. Schorey Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo Blood, November 1, 2007; 110(9): 3234 - 3244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhatnagar and J. S. Schorey Exosomes Released from Infected Macrophages Contain Mycobacterium avium Glycopeptidolipids and Are Proinflammatory J. Biol. Chem., August 31, 2007; 282(35): 25779 - 25789. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bagnato, J. Thumar, V. Mayya, S.-I. Hwang, H. Zebroski, K. P. Claffey, C. Haudenschild, J. K. Eng, D. H. Lundgren, and D. K. Han Proteomics Analysis of Human Coronary Atherosclerotic Plaque: A Feasibility Study of Direct Tissue Proteomics by Liquid Chromatography and Tandem Mass Spectrometry Mol. Cell. Proteomics, June 1, 2007; 6(6): 1088 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. K. Lim and S. Pervaiz Annexin 1: the new face of an old molecule FASEB J, April 1, 2007; 21(4): 968 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Scannell, M. B. Flanagan, A. deStefani, K. J. Wynne, G. Cagney, C. Godson, and P. Maderna Annexin-1 and Peptide Derivatives Are Released by Apoptotic Cells and Stimulate Phagocytosis of Apoptotic Neutrophils by Macrophages J. Immunol., April 1, 2007; 178(7): 4595 - 4605. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Gekonge, G. Schiralli, R. A. Schlegel, and A. J. Henderson Signal transduction induced by apoptotic cells inhibits HIV transcription in monocytes/macrophages J. Leukoc. Biol., October 1, 2006; 80(4): 953 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maderna, S. Yona, M. Perretti, and C. Godson Modulation of Phagocytosis of Apoptotic Neutrophils by Supernatant from Dexamethasone-Treated Macrophages and Annexin-Derived Peptide Ac2-26 J. Immunol., March 15, 2005; 174(6): 3727 - 3733. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ravassa, A. Bennaghmouch, H. Kenis, T. Lindhout, T. Hackeng, J. Narula, L. Hofstra, and C. Reutelingsperger Annexin A5 Down-regulates Surface Expression of Tissue Factor: A NOVEL MECHANISM OF REGULATING THE MEMBRANE RECEPTOR REPERTOIR J. Biol. Chem., February 18, 2005; 280(7): 6028 - 6035. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ma, T. Greenwell-Wild, K. Lei, W. Jin, J. Swisher, N. Hardegen, C. T. Wild, and S. M. Wahl Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection J. Exp. Med., November 15, 2004; 200(10): 1337 - 1346. [Abstract] [Full Text] [PDF] |
||||